Sun Pharmaceuticals Industries Ltd SUNPHARMA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Sun Pharma Presents New Clinical Efficacy and Safety Data in Severe Dermatological Conditions at the 2024 European Academy of Dermatology and Venereology (EADV) Congress
-
Pharmazz Inc. and Sun Pharma entered into an agreement under which Sun Pharma will invest up to $15 Million in Pharmazz, Inc.
-
Sun Pharmaceutical to Take Taro Private at $43/Share
-
Biofrontera Says Sun Pharmaceutical Alleging Breach of Contract In Lawsuit
Trading Information
- Previous Close Price
- ₹1,910.85
- Day Range
- ₹1,903.65–1,952.25
- 52-Week Range
- ₹1,068.35–1,960.35
- Bid/Ask
- ₹1,910.05 / ₹1,907.95
- Market Cap
- ₹4.58 Tril
- Volume/Avg
- 2.8 Mil / 2.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 42.95
- Price/Sales
- 9.44
- Dividend Yield (Trailing)
- 0.71%
- Dividend Yield (Forward)
- 0.71%
- Total Yield
- 0.72%
Company Profile
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company’s substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 19,530
- Website
- https://www.sunpharma.com
Comparables
Valuation
|
Metric
|
SUNPHARMA
|
530199
|
INNOVACAP
|
|---|---|---|---|
Price/Earnings (Normalized) | 42.95 | 50.05 | 35.60 |
Price/Book Value | 7.20 | 6.62 | 5.08 |
Price/Sales | 9.44 | 6.21 | 3.28 |
Price/Cash Flow | 42.22 | 70.79 | 30.05 |
Price/Earnings
SUNPHARMA
530199
INNOVACAP
Financial Strength
|
Metric
|
SUNPHARMA
|
530199
|
INNOVACAP
|
|---|---|---|---|
Quick Ratio | 1.81 | 1.22 | 1.42 |
Current Ratio | 2.56 | 1.90 | 2.18 |
Interest Coverage | 51.23 | 9.20 | 9.62 |
Quick Ratio
SUNPHARMA
530199
INNOVACAP
Profitability
|
Metric
|
SUNPHARMA
|
530199
|
INNOVACAP
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
SUNPHARMA
530199
INNOVACAP
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Cdqvxlcgn | Cjfk | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Qvkmmyqqwq | Rmsnq | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Mrzdtdbc | Fhzw | $46.6 Bil | |||
| Viatris Inc
VTRS
| Xbcdxdhd | Dnpx | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Sgvmrcc | Qvyny | $13.2 Bil | |||
| Catalent Inc
CTLT
| Dgsszjwk | Nrmbhtq | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Htmqmyb | Qdgps | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Xnyfllzq | Xjql | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Nkpltdwk | Dzwp | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Hnddvpj | Fgr | $2.2 Bil |
United States